309 related articles for article (PubMed ID: 23109296)
1. Chemotherapy and cognitive complaints in women with breast cancer.
Pullens MJ; De Vries J; Van Warmerdam LJ; Van De Wal MA; Roukema JA
Psychooncology; 2013 Aug; 22(8):1783-9. PubMed ID: 23109296
[TBL] [Abstract][Full Text] [Related]
2. Health care utilization one year following the diagnosis benign breast disease or breast cancer.
Keyzer-Dekker CM; Van Esch L; Schreurs WH; van Berlo CL; Roukema JA; De Vries J; van der Steeg AF
Breast; 2012 Dec; 21(6):746-50. PubMed ID: 22349348
[TBL] [Abstract][Full Text] [Related]
3. The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer: a prospective study.
Keyzer-Dekker CM; de Vries J; Mertens MC; Roukema JA; van der Steeg AF
Br J Health Psychol; 2014 Nov; 19(4):783-94. PubMed ID: 25295696
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
[TBL] [Abstract][Full Text] [Related]
5. Determinants of fatigue 6 and 12 months after surgery in women with early-stage breast cancer: a comparison with women with benign breast problems.
De Vries J; Van der Steeg AF; Roukema JA
J Psychosom Res; 2009 Jun; 66(6):495-502. PubMed ID: 19446708
[TBL] [Abstract][Full Text] [Related]
6. Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue.
Li J; Yu L; Long Z; Li Y; Cao F
Psychooncology; 2015 Jun; 24(6):676-82. PubMed ID: 25345397
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors are not the best predictors of quality of sexual life and sexual functioning in women with early stage breast cancer.
Den Oudsten BL; Van Heck GL; Van der Steeg AF; Roukema JA; De Vries J
Psychooncology; 2010 Jun; 19(6):646-56. PubMed ID: 19771575
[TBL] [Abstract][Full Text] [Related]
8. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
9. Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast.
De Vries J; Van der Steeg AF; Roukema JA
Br J Health Psychol; 2009 Feb; 14(Pt 1):143-57. PubMed ID: 18544184
[TBL] [Abstract][Full Text] [Related]
10. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
13. Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study.
Hyphantis T; Almyroudi A; Paika V; Degner LF; Carvalho AF; Pavlidis N
Psychooncology; 2013 Nov; 22(11):2470-7. PubMed ID: 23712915
[TBL] [Abstract][Full Text] [Related]
14. What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery?
Lockefeer JP; De Vries J
Psychooncology; 2013 May; 22(5):1127-33. PubMed ID: 22692984
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
Lueboonthavatchai P
J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
[TBL] [Abstract][Full Text] [Related]
16. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
18. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
19. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
20. Correlations between state anxiety and quality of life in metastatic breast cancer patients.
Dragomir BI; Fodoreanu L
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):610-5. PubMed ID: 24502024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
